Floatz logo

Posaconazole

Invasive Aspergillosis

University Hospital, BrestSmall moleculeDormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Invasive Aspergillosis cohort.

Asset / SponsorPhaseRating
CYCLO(-ASN-LEU-D-PHE-AL((N5-ACETYL-N5-HYDROXY-ORN)-(N5-ACETYL-N5-HYDROXY-ORN)-(N5-HYDROXY-ORN))-) . AL(III)
Vical
Phase 2CCC
AMPHOTERICIN
Vical
Phase 2CCC
Voriconazole
Vical
Phase 2CCC
Isavuconazole
Vical
Phase 2CCC

Same molecule, other indications

Posaconazole is also rated in:

acute myeloid leukemiaDormant
BBB
Indicative ·
74 / 100
View asset →
fungal infectious diseaseDormant
BB
Indicative ·
70 / 100
View asset →
neutropeniaDormant
BB
Indicative ·
67 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →